Phenotyping of Patients With Polycystic Ovary Syndrome

Recruiting now

Conditions studied: Polycystic Ovary Syndrome (PCOS)

In brief

Polycystic ovary syndrome (PCOS) is the leading endocrine disorder of the reproductive system, affecting 10 to 13% of women of childbearing age. However, there is a significant delay in diagnosis, which may be due to considerable clinical heterogeneity and a lack of information among the general population. The diagnosis is made when two of the three Rotterdam criteria established in 2003 and revised in 2023 are met, namely: 1) menstrual cycle disorders (oligoanovulation) - 2) clinical or biological hyperandrogenism - 3) OPK morphological appearance or elevated anti-Müllerian hormone (AMH) levels, after exclusion of differential diagnoses. PCOS is a condition that carries a risk of metabolic complications and fertility problems due to dysovulation. Patients have an impaired quality of life and are at greater risk of anxiety and depression, which should be screened for systematically.

Key facts

Study ID

NCT07339930

Run by

University Hospital, Strasbourg, France

People needed

100

Starts

2025-09-17

Expected to finish

2026-09-17

Last updated by the study team

2026-01-14

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult woman (≥18 years and <50 years)
• Subject who consulted at the Strasbourg University Hospitals for suspected PCOS or for any other endocrinological condition that led to the discovery of PCOS.

You may not qualify if…

• Final diagnosis excluding PCOS.

Where it is running

• ervice d'Endocrinologie, Diabétologie et Nutrition - CHU de Strasbourg - France — Strasbourg, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.